Permanens Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,400
Closed -$226K 46
2021
Q3
$226K Sell
1,400
-400
-22% -$68.2K 0.04% 42
2021
Q2
$297K Hold
1,800
0.05% 43
2021
Q1
$296K Buy
1,800
+400
+29% +$64.7K 0.06% 58
2020
Q4
$220K Buy
1,400
+800
+133% +$118K 0.05% 58
2020
Q3
$89K Sell
600
-800
-57% -$118K 0.03% 65
2020
Q2
$197K Buy
1,400
+1,000
+250% +$146K 0.07% 27
2020
Q1
$52K Buy
400
+200
+100% +$28.4K 0.02% 63
2019
Q4
$29K Sell
200
-200
-50% -$27.1K 0.01% 91
2019
Q3
$52K Buy
400
+100
+33% +$13.2K 0.01% 59
2019
Q2
$42K Buy
300
+100
+50% +$13.8K 0.01% 57
2019
Q1
$28K Buy
+200
New +$26.8K 0.01% 59

Other funds holding JNJ

Permanens Capital's JNJ Position: Q4 2021 in Review

Permanens Capital sold out of Johnson & Johnson (JNJ) in Q4 2021, closing a stake of 1,400 shares — an estimated $226K sold.

Permanens Capital first reported a position in JNJ in Q1 2019 and held it in 11 quarters. The position peaked at $297K in Q2 2021. 3,644 funds tracked by Wall St. Rank hold JNJ as of Q4 2021.

  • Permanens Capital reported no remaining Johnson & Johnson position as of Q4 2021 after selling out during the quarter.
  • Permanens Capital sold 1,400 Johnson & Johnson shares in Q4 2021, an estimated $226K.
  • Permanens Capital first reported a position in Johnson & Johnson in Q1 2019 and held it in 11 quarters.
  • Permanens Capital's Johnson & Johnson position peaked at $297K in Q2 2021.
  • 3,644 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2021.

Based on Permanens Capital's 13F filing for Q4 2021, filed 14 Feb 2022.